Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.34 EUR | -.--% | -.--% | -.--% |
Apr. 29 | Fitch Maintains CRH's Ratings on Strong Business Profile, Operating Performance | MT |
Apr. 25 | UK-listed drugmaker Indivior seeks shareholder nod for US listing | RE |
Sales 2024 * | 34.04B 36.54B | Sales 2025 * | 35.56B 38.17B | Capitalization | 50.8B 54.53B |
---|---|---|---|---|---|
Net income 2024 * | 3.42B 3.67B | Net income 2025 * | 3.53B 3.79B | EV / Sales 2024 * | 1.64 x |
Net Debt 2024 * | 5.05B 5.43B | Net Debt 2025 * | 4.1B 4.4B | EV / Sales 2025 * | 1.54 x |
P/E ratio 2024 * |
15.2
x | P/E ratio 2025 * |
14.5
x | Employees | 78,500 |
Yield 2024 * |
1.77% | Yield 2025 * |
1.89% | Free-Float | 93.62% |
Latest transcript on CRH plc
Managers | Title | Age | Since |
---|---|---|---|
Albert Manifold
CEO | Chief Executive Officer | 61 | 97-12-31 |
Jim Mintern
DFI | Director of Finance/CFO | 57 | 21-05-31 |
Randy Lake
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Fearon
BRD | Director/Board Member | 67 | 20-12-02 |
Johan Karlström
BRD | Director/Board Member | 67 | 19-09-24 |
Siobhán Talbot
BRD | Director/Board Member | 60 | 18-11-30 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.25% | 36.42B | |
-4.90% | 34.44B | |
+16.48% | 34.34B | |
+14.97% | 19.61B | |
+16.90% | 18.4B | |
+21.31% | 18.29B | |
+4.54% | 11.53B | |
+1.66% | 6.88B | |
+19.34% | 4.4B |
- Stock Market
- Equities
- CRH Stock
- CRG Stock